Related references
Note: Only part of the references are listed.Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania
Saumu Pazia Juma et al.
BMC INFECTIOUS DISEASES (2019)
Myocardial blood flow and myocardial flow reserve values in 13N-ammonia myocardial perfusion PET/CT using a time-efficient protocol in patients without coronary artery disease
Opstal TSJ et al.
EUROPEAN JOURNAL OF HYBRID IMAGING (2018)
pncA mutations are associated with slower sputum conversion during standard treatment of multidrug-resistant tuberculosis
Xubin Zheng et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Increased Tuberculosis Patient Mortality Associated with Mycobacterium tuberculosis Mutations Conferring Resistance to Second-Line Antituberculous Drugs
Sophia B. Georghiou et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China
Yu Pang et al.
BMC INFECTIOUS DISEASES (2017)
Multidrug-resistant tuberculosis (MDR-TB) disease burden in China: a systematic review and spatio-temporal analysis
Peipei Ding et al.
BMC INFECTIOUS DISEASES (2017)
Specific gyrA gene mutations predict poor treatment outcome in MDR-TB
L. Rigouts et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Pyrazinamide resistance in Mycobacterium tuberculosis: Review and update
Moses Njire et al.
ADVANCES IN MEDICAL SCIENCES (2016)
Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China
Dange Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis
B. Velayutham et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables
Priti Kambli et al.
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY (2016)
Defining multidrug-resistant tuberculosis: correlating GenoType MTBDRplus assay results with minimum inhibitory concentrations
Priti Kambli et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2015)
Molecular characterisation of extensively drug-resistant Mycobacterium tuberculosis isolates in China
Li-li Zhao et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan
A. Akhmetova et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
WHO's new End TB Strategy
Mukund Uplekar et al.
LANCET (2015)
Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay
Priti Kambli et al.
TUBERCULOSIS (2015)
Genotypic Susceptibility Testing of Mycobacterium tuberculosis Isolates for Amikacin and Kanamycin Resistance by Use of a Rapid Sloppy Molecular Beacon-Based Assay Identifies More Cases of Low-Level Drug Resistance than Phenotypic Lowenstein-Jensen Testing
Soumitesh Chakravorty et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Treatment outcomes and moxifloxacin susceptibility in ofloxacin-resistant multidrug-resistant tuberculosis
K-W. Jo et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Role of pncA and rpsA Gene Sequencing in Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates from Southern China
Yaoju Tan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Defining Catastrophic Costs and Comparing Their Importance for Adverse Tuberculosis Outcome with Multi-Drug Resistance: A Prospective Cohort Study, Peru
Tom Wingfield et al.
PLOS MEDICINE (2014)
Resistance to fluoroquinolones and second-Line injectable drugs: impact on multidrug-resistant TB outcomes
Dennis Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Gene Sequencing for Routine Verification of Pyrazinamide Resistance in Mycobacterium tuberculosis: a Role for pncA but Not rpsA
David C. Alexander et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
National Survey of Drug-Resistant Tuberculosis in China
Yanlin Zhao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: a Systematic Review with Meta-Analyses
Kwok Chiu Chang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Treatment Outcomes of Isoniazid-Resistant Tuberculosis Patients, Western Cape Province, South Africa
Karen R. Jacobson et al.
CLINICAL INFECTIOUS DISEASES (2011)
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
Wanliang Shi et al.
SCIENCE (2011)
Comparison of rifabutin susceptibility and rpoB mutations in multi-drug-resistant Mycobacterium tuberculosis strains by DNA sequencing and the line probe assay
Shiomi Yoshida et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2010)
Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB
S. S. Hwang et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis
Dick Menzies et al.
PLOS MEDICINE (2009)
Detection of isoniazid-resistant Mycobacterium tuberculosis strains by a multiplex allele-specific PCR assay targeting katG codon 315 variation
I Mokrousov et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Share Paper
